Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.

Palmer SM, Limaye AP, Banks M, Gallup D, Chapman J, Lawrence EC, Dunitz J, Milstone A, Reynolds J, Yung GL, Chan KM, Aris R, Garrity E, Valentine V, McCall J, Chow SC, Davis RD, Avery R.

Ann Intern Med. 2010 Jun 15;152(12):761-9. doi: 10.7326/0003-4819-152-12-201006150-00003.

PMID:
20547904
[PubMed - indexed for MEDLINE]
2.

The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation.

Lapidus-Krol E, Shapiro R, Amir J, Davidovits M, Steinberg R, Mor E, Avitzur Y.

Pediatr Transplant. 2010 Sep 1;14(6):753-60. doi: 10.1111/j.1399-3046.2010.01330.x. Epub 2010 May 3.

PMID:
20477976
[PubMed - indexed for MEDLINE]
3.

Valganciclovir: recent progress.

Pescovitz MD.

Am J Transplant. 2010 Jun;10(6):1359-64. doi: 10.1111/j.1600-6143.2010.03112.x. Epub 2010 Mar 28. Review.

PMID:
20455881
[PubMed - indexed for MEDLINE]
Free Article
4.

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P.

Am J Transplant. 2010 May;10(5):1228-37. doi: 10.1111/j.1600-6143.2010.03074.x. Epub 2010 Mar 26.

PMID:
20353469
[PubMed - indexed for MEDLINE]
Free Article
5.

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A; Transplantation Society International CMV Consensus Group.

Transplantation. 2010 Apr 15;89(7):779-95. doi: 10.1097/TP.0b013e3181cee42f.

PMID:
20224515
[PubMed - indexed for MEDLINE]
6.

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy.

Kalil AC, Freifeld AG, Lyden ER, Stoner JA.

PLoS One. 2009;4(5):e5512. doi: 10.1371/journal.pone.0005512. Epub 2009 May 13.

PMID:
19436751
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients.

Vaudry W, Ettenger R, Jara P, Varela-Fascinetto G, Bouw MR, Ives J, Walker R; Valcyte WV16726 Study Group.

Am J Transplant. 2009 Mar;9(3):636-43. doi: 10.1111/j.1600-6143.2008.02528.x.

PMID:
19260840
[PubMed - indexed for MEDLINE]
Free Article
8.

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients.

Brady RL, Green K, Frei C, Maxwell P.

Transpl Infect Dis. 2009 Apr;11(2):106-11. doi: 10.1111/j.1399-3062.2008.00356.x.

PMID:
19054381
[PubMed - indexed for MEDLINE]
9.

Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review.

Sun HY, Wagener MM, Singh N.

Am J Transplant. 2008 Oct;8(10):2111-8. doi: 10.1111/j.1600-6143.2008.02369.x. Review.

PMID:
18828771
[PubMed - indexed for MEDLINE]
Free Article
10.

Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.

Len O, Gavaldà J, Aguado JM, Borrell N, Cervera C, Cisneros JM, Cuervas-Mons V, Gurguí M, Martin-Dávila P, Montejo M, Muñoz P, Bou G, Carratalà J, Torre-Cisneros J, Pahissa A; RESITRA.

Clin Infect Dis. 2008 Jan 1;46(1):20-7. doi: 10.1086/523590.

PMID:
18171208
[PubMed - indexed for MEDLINE]
Free Article
11.

A survey of CMV prevention strategies after liver transplantation.

Levitsky J, Singh N, Wagener MM, Stosor V, Abecassis M, Ison MG.

Am J Transplant. 2008 Jan;8(1):158-61. Epub 2007 Oct 31.

PMID:
17973961
[PubMed - indexed for MEDLINE]
Free Article
12.

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.

Cervera C, Pineda M, Linares L, Marcos MA, Esteva C, Antón A, Cofán F, Ricart MJ, Navasa M, Pérez-Villa F, Pumarola T, Moreno A.

Transplant Proc. 2007 Sep;39(7):2228-30.

PMID:
17889146
[PubMed - indexed for MEDLINE]
13.

Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?

Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, Menegus M, Ryan C, Bozorgzadeh A.

Transplant Proc. 2005 Sep;37(7):3182-6.

PMID:
16213344
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.

Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD; Valganciclovir Solid Organ Transplant Study Group.

Am J Transplant. 2004 Apr;4(4):611-20.

PMID:
15023154
[PubMed - indexed for MEDLINE]
Free Article
15.

Quantitative analysis of CMV DNA in children the first year after liver transplantation.

Kullberg-Lindh C, Ascher H, Krantz M, Lindh M.

Pediatr Transplant. 2003 Aug;7(4):296-301.

PMID:
12890008
[PubMed - indexed for MEDLINE]
16.

Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Bueno J, Ramil C, Green M.

Paediatr Drugs. 2002;4(5):279-90. Review.

PMID:
11994033
[PubMed - indexed for MEDLINE]
17.

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.

Pescovitz MD, Rabkin J, Merion RM, Paya CV, Pirsch J, Freeman RB, O'Grady J, Robinson C, To Z, Wren K, Banken L, Buhles W, Brown F.

Antimicrob Agents Chemother. 2000 Oct;44(10):2811-5.

PMID:
10991864
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

Noble S, Faulds D.

Drugs. 1998 Jul;56(1):115-46. Review.

PMID:
9664203
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk